Jpmorgan Chase & CO Dr Reddys Laboratories LTD Transaction History

Jpmorgan Chase & CO

$1.1 Trillion
Q1 2024

A detailed history of Jpmorgan Chase & CO transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Jpmorgan Chase & CO holds 260,103 shares of RDY stock, worth $19.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

260,103

Previous 36,242 617.68%

Holding current value

$19.8 Million

Previous $2.52 Million 656.76%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$67.36 - $77.59 $15.1 Million - $17.4 Million	223,861 Added 617.68%	260,103 $19.1 Million
Q4 2023 Feb 12, 2024	BUY	$64.27 - $69.9 $142,486 - $154,968	2,217 Added 6.52%	36,242 $2.52 Million
Q3 2023 Nov 14, 2023	SELL	$61.9 - $72.77 $1.86 Million - $2.19 Million	-30,029 Reduced 46.88%	34,025 $2.28 Million
Q2 2023 Aug 11, 2023	BUY	$53.34 - $63.11 $2.63 Million - $3.12 Million	49,385 Added 336.66%	64,054 $4.04 Million
Q1 2023 May 11, 2023	SELL	$51.63 - $56.93 $173,838 - $191,683	-3,367 Reduced 18.67%	14,669 $835,000

Q4 2022 Feb 13, 2023	SELL	$51.15 - $57.45 $16.2 Million - $18.2 Million	-316,168 Reduced 94.6%	18,036 $933,000
Q3 2022 Nov 14, 2022	BUY	$49.9 - $57.32 $2.62 Million - $3.01 Million	52,535 Added 18.65%	334,204 $17.5 Million
Q2 2022 Aug 11, 2022	SELL	$49.62 - $58.13 $11.1 Million - $13 Million	-222,786 Reduced 44.16%	281,669 $15.6 Million
Q1 2022 May 11, 2022	BUY	$48.27 - $65.25 $17.5 Million - $23.7 Million	363,306 Added 257.39%	504,455 $28.1 Million
Q4 2021 Feb 10, 2022	SELL	$59.5 - $67.25 $3.45 Million - $3.9 Million	-57,984 Reduced 29.12%	141,149 $9.23 Million
Q3 2021 Nov 12, 2021	BUY	$60.19 - $75.29 $12 Million - $15 Million	199,133 New	199,133 $13 Million

Others Institutions Holding RDY

# of Institutions

242

Shares Held

23.6M

Call Options Held

25.2K

Put Options Held

8.5K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $12.6B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Dr Reddys Laboratories LTD Transaction History